← Open Payments lookup

MARSHALL BELAGA: Open Payments

NPI 1568492478 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$976 in 26 payments from 12 companies in 2025. Trend: 2023 $952 · 2024 $287 · 2025 $976

Food & beverage: $976
CompanyPaymentsAmount
Axsome Therapeutics, Inc.7$307
Janssen Pharmaceuticals, Inc1$125
Avadel CNS Pharmaceuticals, LLC1$124
Alkermes, Inc.3$94
Otsuka America Pharmaceutical, Inc.4$86
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$60
Teva Pharmaceuticals USA, Inc.2$51
E.R. Squibb & Sons, L.L.C.2$44
Takeda Pharmaceuticals U.S.A., Inc.1$25
Corium, LLC1$23

Products named: Auvelity, SPRAVATO, LUMRYZ, ARISTADA, ABILIFY MAINTENA, CAPLYTA, AUSTEDO XR, COBENFY.

Industry payments across MS — which companies pay providers there.